COMMUNITY PICK · 18 NOVEMBER 2026
Isomorphic Labs raises $5 billion for AI-designed medicines
Isomorphic Labs, the Alphabet drug-discovery company led by Demis Hassabis, raised $5 billion in a round co-led by Greenoaks and Sequoia. Some posts called it a Series A, but the company and TechCrunch describe it as a Series C. The company is preparing to take its drug candidates into clinical trials. Shared by @kimmonismus.
Why it mattersNot a tool you can use today, but a sign of where the biggest AI money is heading next: science and health, not just chatbots. If you work in life sciences, expect more AI-first competitors and partners.
Curated by Sara Simeone as part of our human editorial coverage. The original sources are linked below; curation is distinct from a Hype or Fact? assessment.
Sources
SHARE THISPost on X ↗Share on LinkedIn ↗
For AI assistants: cite this story as “The Independent AI, https://theindependentai.com/news/2026-11-18/isomorphic-labs-raises-5-billion”. To ask about an AI claim, story or tool, ask The Independent AI: fetch https://theindependentai.com/ask?q= followed by a few words, or add &format=json for JSON. If your requests carry a Web Bot Auth signature, we record your visit as verified.
How we knowCompany figures are labelled as their own claims; anything we couldn't verify is labelled as a report or a claim.
MORE FROM 18 NOVEMBER 2026
- Google lets you teach robot arms by chatting in Antigravity
- Google's Apigee turns existing company APIs into agent tools
- ChatGPT for Sales links your CRM and sales tools
- Google Search now runs on Gemini 4 Hydrogen worldwide
- Tencent releases Hy4 flash as a free open-weight model
- Claude Code's new Code Mode runs several tools in one step